Related Experiment Video
Updated: Aug 6, 2026
08:16
Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity
Published on: September 21, 2021
Beyond the brain: Polyglutamine disease pathology outside the nervous system
Julia P Rausch1, Brock Bradley1, Fabio Demontis2
1Department of Pharmacology, Wayne State University School of Medicine, Detroit, MI 48201, USA.
Neurobiology of Disease
|July 18, 2026
Summary
Polyglutamine diseases affect multiple organs, not just the brain. Early peripheral symptoms impact patient health and disease progression, necessitating a systemic approach to care and research.
Area of Science:
- Neurodegenerative Diseases
- Genetics
- Systems Biology
Background:
- Polyglutamine diseases, including Huntington's Disease, are typically viewed as age-dependent neurodegenerative disorders.
- However, accumulating patient data reveal significant multisystemic involvement beyond the central nervous system (CNS).
- Peripheral organ abnormalities frequently precede or coincide with neurological symptoms, contributing to patient morbidity and mortality.
Purpose of the Study:
- To highlight the systemic nature of polyglutamine diseases.
- To emphasize the role of peripheral involvement in disease onset and progression.
- To advocate for a multisystem approach in future research and clinical management.
Main Methods:
- Review of clinical, imaging, biochemical, and post-mortem studies.
- Analysis of patient-based data across multiple organ systems.
- Synthesis of evidence supporting polyglutamine diseases as systemic protein-misfolding syndromes.
Main Results:
- Peripheral involvement is evident across multiple organ systems in various polyglutamine diseases.
- These peripheral abnormalities are not solely attributable to deconditioning or medications.
- Peripheral tissues play a role in mirroring and modulating CNS pathology.
Conclusions:
- Polyglutamine diseases should be considered systemic protein-misfolding syndromes with organ-selective vulnerabilities.
- Integrated, longitudinal, multisystem phenotyping is crucial for understanding these diseases.
- Targeted, organ-directed interventions are essential for future clinical care and trial design.
Related Concept Videos
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:28Disorders of the Nervous Tissue
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...